| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/22/2010 | US20100099728 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | US20100099725 Peroxisome proliferator activated receptor modulators |
| 04/22/2010 | US20100099721 Novel compounds for the treatment of neurological disorders |
| 04/22/2010 | US20100099716 Cetp inhibitors |
| 04/22/2010 | US20100099714 AMPA and NMDA Receptor Antagonists for Neurodegenerative Diseases |
| 04/22/2010 | US20100099693 New combination for use in the treatment of inflammatory disorders |
| 04/22/2010 | US20100099691 Pyrimidinyl pyridone inhibitors of jnk |
| 04/22/2010 | US20100099690 Xanthine derivatives as selective hm74a agonists |
| 04/22/2010 | US20100099689 Methods of modulating ppar gamma-type receptors |
| 04/22/2010 | US20100099681 Substituted 5-aminopyrazoles and use thereof |
| 04/22/2010 | US20100099673 Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| 04/22/2010 | US20100099657 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity |
| 04/22/2010 | US20100099617 Secreted proteins |
| 04/22/2010 | US20100099611 Anti-angiogenic peptides |
| 04/22/2010 | US20100098768 Method of neuroprotection from oxidant injury using metal oxide nanoparticles |
| 04/22/2010 | US20100098756 Oral disintegrating tablet |
| 04/22/2010 | US20100098753 Prophylactic and/or therapeutic agent for cardiac infarction |
| 04/22/2010 | US20100098747 Percutaneous administration device of bisoprolol |
| 04/22/2010 | US20100098740 Method of controlling a drug release rate |
| 04/22/2010 | US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 04/22/2010 | US20100098711 Antagonist antibodies against ephb3 |
| 04/22/2010 | US20100098709 Antibodies Specific For The Complex Of Interleukin-6 And The Interleukin-6 Receptor |
| 04/22/2010 | US20100098685 Use of Inhibitors of Toll-Like Receptors in the Prevention and Treatment of Hypercholesterolemia and Hyperlipidemia and Diseases Related Thereto |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098676 Synergistic anti-inflammatory and antioxidant dietary supplement compositions |
| 04/22/2010 | US20100098308 Pulmonary Emboli Detection with Dynamic Configuration Based on Blood Contrast Level |
| 04/22/2010 | CA2741060A1 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders |
| 04/22/2010 | CA2740785A1 Modulation of factor 11 expression |
| 04/22/2010 | CA2740696A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/22/2010 | CA2740568A1 Compositions and methods for treating or preventing hypoxic or ischemic injury |
| 04/22/2010 | CA2740557A1 Annexin and its use to treat inflammatory disorders |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | CA2739488A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2738757A1 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury |
| 04/22/2010 | CA2738614A1 Drop pill for treating coronary heart disease and preparation thereof |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2177530A1 Octapeptide having antiangiogenic activity |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP2177518A1 Organic compounds |
| 04/21/2010 | EP2177513A1 Phenylacetic acid compound |
| 04/21/2010 | EP2177227A1 Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency |
| 04/21/2010 | EP2177224A2 Agents for preventing and treating disorders involving modulation of the RyR receptors |
| 04/21/2010 | EP2176253A2 A process for the preparation or purification of olmesartan medoxomil |
| 04/21/2010 | EP2176238A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 04/21/2010 | EP2175874A2 Use of peptidic vasopressin receptor agonists |
| 04/21/2010 | EP2175872A2 Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction |
| 04/21/2010 | EP2175853A1 Methods of treating metabolic syndrome using dopamine receptor agonists |
| 04/21/2010 | EP2175852A1 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 04/21/2010 | EP1887005B1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
| 04/21/2010 | EP1853270B1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 04/21/2010 | EP1818329B1 (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2methyl-1,4homopiperazine hydrochloride dihydrate |
| 04/21/2010 | EP1479670B1 Novel fused ring indazole compounds |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | EP1258252B1 Integrin expression inhibitors |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | EP0870033B1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 04/21/2010 | CN1965848B Lyophilized powder injection of breviscapinum and preparation process thereof |
| 04/21/2010 | CN1935236B Quality control method for Chinese medicine injection preparation |
| 04/21/2010 | CN1931269B Rutin containing medicine composition |
| 04/21/2010 | CN1923820B Novel carboxylic acid derivatives, their preparation and use |
| 04/21/2010 | CN1895354B Chinese-medicinal Bastian-Bruns agent for treating coronary heart disease and angina cordis and its making method |
| 04/21/2010 | CN1891296B Medicinal composition containing calcium agonist and phenoxy acid compound |
| 04/21/2010 | CN1872297B Application of medication composition of Guangdong date in preparing medicine for treating chronic insufficiency of blood supply for brain |
| 04/21/2010 | CN1823604B Seaweed tea and its preparation method |
| 04/21/2010 | CN1795195B Pyridopyrazines and the use thereof as kinase inhibitors |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN1698668B Motherwort extract dispersed tablet and preparation method of motherwort extract |
| 04/21/2010 | CN1689628B Medical purpose of creat extract |
| 04/21/2010 | CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 04/21/2010 | CN101696386A Highland barley monascus healthy wine and brewing method thereof |
| 04/21/2010 | CN101696233A Albumin angiotensin converting enzyme inhibition peptide and preparation method thereof |
| 04/21/2010 | CN101696229A Curcumin A as well as preparation method thereof and applications to preparing medicaments for treating cardiovascular and cerebrovascular diseases |
| 04/21/2010 | CN101696208A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 04/21/2010 | CN101696183A (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof |
| 04/21/2010 | CN101696166A Preparation method for danshen root salvianolic acid A |
| 04/21/2010 | CN101695549A Chinese medicinal herb hemorrhoid comforting pill |
| 04/21/2010 | CN101695543A Composition for treating arrhythmia and preparation method thereof |
| 04/21/2010 | CN101695541A Composition for treating ischemic heart disease and preparation method thereof |
| 04/21/2010 | CN101695538A Traditional Chinese medicinal preparation for treating coronary heart disease and preparation method thereof |
| 04/21/2010 | CN101695528A Medicament for purifying blood |
| 04/21/2010 | CN101695518A Method for extracting total alkaloid of common fibraurea stems, separate fibriuretinin and jatrorrhizine |
| 04/21/2010 | CN101695496A Medicinal composition containing triflusal and clopidogrel |
| 04/21/2010 | CN101695495A Composition for treatment of external secretion disorders |
| 04/21/2010 | CN101695475A Ozagrel sodium injection and preparation method thereof |
| 04/21/2010 | CN101249085B Bilobalide A, B compound injection and preparation method and application thereof |
| 04/21/2010 | CN101036637B Application of salvia miltiorrhiza bge I sodium sulfonate in the preparation of medicine |
| 04/21/2010 | CN101018846B Method for producing unsaturated fatty acid concentrate |
| 04/21/2010 | CN100998626B Method for preparing extract of korea thistle leaf |
| 04/20/2010 | US7700657 Vitamin D analogs |
| 04/20/2010 | US7700653 Hypotensive agents; cardiovascular disorders |
| 04/20/2010 | US7700635 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitorsfor seine/threonine kinases, phosphatases; Alzheimer's |
| 04/20/2010 | US7700610 Use of tyrosine kinase inhibitors for treating allergic diseases |
| 04/20/2010 | US7700600 Using vanoxerine type medicant; blocking calcium channel current |
| 04/20/2010 | US7700595 such as 3-benzyl-4-phenyl-8-(trifluoromethyl)cinnoline; modulators of Liver X receptors (LXRs) |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700582 Pharmaceutical formulation |
| 04/20/2010 | US7700562 Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700557 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 04/20/2010 | US7700554 Compositions for modulating blood-brain barrier transport |